Related Experiment Video
Updated: Jul 13, 2026
16:59
Neo-Islet Formation in Liver of Diabetic Mice by Helper-dependent Adenoviral Vector-Mediated Gene Transfer
Published on: October 10, 2012
Viral infection--a cure for type 1 diabetes?
Edith Hintermann1, Urs Christen
1Pharmazentrum Frankfurt / ZAFES, Johann Wolfgang Goethe University, Frankfurt am Main, Germany.
Current Medicinal Chemistry
|August 19, 2007
Summary
Viruses may trigger or halt autoimmune diseases. Research explores the link between viral infections and conditions like type 1 diabetes, with potential therapeutic applications.
Area of Science:
- Immunology
- Virology
- Genetics
Background:
- Autoimmune diseases result from genetic and environmental factors.
- Viruses are suspected triggers due to their inflammatory potential.
- Direct proof is challenging as viruses are often cleared by diagnosis.
Purpose of the Study:
- To review epidemiological and experimental evidence linking viruses to autoimmune diseases.
- To examine the dual role of viruses in initiating and abrogating autoimmunity.
- To evaluate potential therapeutic uses of these findings.
Main Methods:
- Review of epidemiological studies on virus-autoimmunity associations.
- Analysis of experimental data from animal models.
- Evaluation of existing literature on viral roles in autoimmune diseases.
Main Results:
- Animal models show viruses can initiate or worsen autoimmune conditions like type 1 diabetes.
- Viruses have also been shown to suppress autoimmune diseases in animal models.
- Hygiene hypothesis may explain increased autoimmune disease prevalence.
Conclusions:
- Viruses play a complex role in autoimmune diseases, potentially triggering or suppressing them.
- Further research is needed to understand these mechanisms for therapeutic development.
- Understanding the virus-autoimmunity link could lead to novel treatments.
More Related Videos
Related Concept Videos
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...